BioNTech SE logo

Senior Director Global Product Strategy - Lung Cancer Therapies

BioNTech SE
Full-time
Remote friendly (Berkeley Heights, NJ)
United States
Marketing

Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too! Try it now — JobsAI.

Role Summary

Senior Director Lung Cancer Portfolio. Strategic, science-driven leadership shaping the future of a high-priority oncology indication with global potential. Focus on new product planning and early commercial strategy, partnering with R&D, clinical, medical, and regulatory teams to inform development decisions and prepare path to launch.

Responsibilities

  • Lead global commercial strategy development for the lung cancer portfolio, with a focus on indication prioritization, early positioning, and value-focused lifecycle strategy
  • Drive new product planning activities from preclinical/early clinical through registrational development, supporting strategic TPP shaping, unmet need assessment, competitive differentiation, and commercial viability
  • Partner cross-functionally with R&D, clinical development, translational research, regulatory, and medical affairs to embed commercial perspectives into key decisions
  • Lead or co-lead commercial input into early launch readiness planning, with emphasis on evidence strategy, access considerations, and strategic stakeholder engagement
  • Provide deep insights into the US oncology market while ensuring alignment with global perspectives
  • Contribute to cross-functional governance processes, development strategy forums, and scenario planning efforts
  • Support external interactions where needed (e.g., advisory boards, co-development partners, select KOL discussions) in alignment with medical and development leadership
  • Work collaboratively across the internal team to ensure that the lung cancer portfolio is progressing in line with both scientific excellence and commercial ambition

Qualifications

  • 8–12+ years of relevant experience in oncology commercial strategy, new product planning, launch readiness, or asset strategy roles
  • Strong track record in solid tumors, ideally with direct or adjacent lung, head and neck cancer experience
  • Significant experience in early-stage commercialization, including product concept shaping, indication assessment, and early launch strategy
  • Ability to partner effectively with R&D, including familiarity with oncology clinical trial design, regulatory pathways, and biomarker-driven development
  • Demonstrated understanding of the US oncology landscape and stakeholder needs; experience/understanding with EU and other major markets
  • Strong scientific acumen combined with a highly strategic mindset and the ability to navigate ambiguity in a pre-commercial environment
  • Experience working in global or cross-regional roles, ideally within biotech or fast-paced oncology-focused companies
  • Advanced degree (PhD, PharmD, MD, or MBA) strongly preferred

Skills

  • Strategic thinking and market access planning
  • Cross-functional collaboration and stakeholder management
  • Global portfolio management and early product planning
  • Evidence generation and commercialisation readiness
  • Biomarker-driven development and regulatory pathway understanding

Education

  • Advanced degree (PhD, PharmD, MD, or MBA) strongly preferred